- Home
- BALL vs BAX Comparison
BALL vs BAX Comparison
Compare BALL & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BALL | BAX |
|---|---|---|
| Founded | 1880 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9B | 13.9B |
| IPO Year | 2009 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BALL | BAX |
|---|---|---|
| Price | $60.99 | $23.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 9 |
| Target Price | ★ $69.00 | $21.00 |
| AVG Volume (30 Days) | 1.5M | ★ 4.4M |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.33% | 0.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.59 | 0.21 |
| Revenue | N/A | ★ $11,244,000,000.00 |
| Revenue This Year | $7.96 | $1.96 |
| Revenue Next Year | $3.51 | $2.22 |
| P/E Ratio | ★ $38.57 | $110.60 |
| Revenue Growth | N/A | ★ 5.72 |
| 52 Week Low | $44.83 | $15.73 |
| 52 Week High | $68.56 | $30.00 |
Technical Indicators
Market Signals| Indicator | BALL | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 48.53 | 35.19 |
| Support Level | $60.85 | $21.28 |
| Resistance Level | $63.68 | $23.62 |
| Average True Range (ATR) | 0.98 | 0.74 |
| MACD | -0.11 | -0.30 |
| Stochastic Oscillator | 48.90 | 13.38 |
Price Performance
Historical ComparisonAbout BALL Ball Corporation
Ball is the world's largest metal can manufacturer with market share over 30% in its three main regions (North America, Europe, and South America). The company is focused on increasing capacity amid a wave of new developed-market demand, while also investing in faster-growing emerging-market economies. Ball spun-off its glass jar business in 1993 and is now owned by Newell. The company reports three segments—beverage packaging, North and Central America (48% of 2025 revenue), beverage packaging, EMEA (30%), beverage packaging, South America (16%)—and it generated $13 billion in revenue in 2025.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.